RFK Jr. allowed widespread access to unapproved peptide injections, overriding FDA advice against their use.
In July, an FDA advisory panel voted to ease restrictions on six peptides, citing insufficient safety and effectiveness evidence. The Department of Health and Human Services will no longer enforce actions against compounding pharmacies producing these peptides.
- An FDA advisory panel voted to loosen restrictions on the six peptides in July.
- The Department of Health and Human Services will no longer take enforcement action against compounding pharmacies for making the six peptides.
Outlets: Ars Technica - All content, CBS News, MyJoyOnline, NBC News, The Hill
Written by AI from the outlets' reporting and checked automatically; it can contain mistakes. How Daily Brief works · Privacy